Related references
Note: Only part of the references are listed.Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient
Banchob Sripa et al.
HUMAN CELL (2020)
Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial
Yang Liu et al.
CYTOTHERAPY (2020)
Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells
Bian Hu et al.
HUMAN GENE THERAPY (2019)
CD133: beyond a cancer stem cell biomarker
Amir Barzegar Behrooz et al.
JOURNAL OF DRUG TARGETING (2019)
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Paola Bertuccio et al.
JOURNAL OF HEPATOLOGY (2019)
Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis
Emma J. M. Grigor et al.
TRANSFUSION MEDICINE REVIEWS (2019)
T Cell-Redirecting Strategies to 'STAb' Tumors: Beyond CARs and Bispecific Antibodies
Belen Blanco et al.
TRENDS IN IMMUNOLOGY (2019)
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
Maria Castella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
Narayanasamy Badrinath et al.
CANCERS (2019)
CAR-T immunotherapies: Biotechnological strategies to improve safety, efficacy and clinical outcome through CAR engineering
Theano I. Panagopoulou et al.
BIOTECHNOLOGY ADVANCES (2019)
Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules
Guoying Zhou et al.
JOURNAL OF HEPATOLOGY (2019)
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
Bryan D. Choi et al.
NATURE BIOTECHNOLOGY (2019)
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
Ru Zhou et al.
FRONTIERS IN IMMUNOLOGY (2019)
Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications
Hsing-Ju Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review
Ming-Liang Wang et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2019)
Common gamma chain cytokines and CD8 T cells in cancer
Mitra Shourian et al.
SEMINARS IN IMMUNOLOGY (2019)
Cholangiocarcinoma: a guide for the nonspecialist
Munirah Alsaleh et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2019)
Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
Ali Yousaf et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment
Yelei Guo et al.
PROTEIN & CELL (2018)
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
Miriam Y. Kim et al.
CELL (2018)
A guide to manufacturing CAR T cell therapies
Philipp Vormittag et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
Driving CARs on the uneven road of antigen heterogeneity in solid tumors
Nan Chen et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
TNF activity and T cells
Amit K. Mehta et al.
CYTOKINE (2018)
Antigenic targets of CAR T Cell Therapy. A retrospective view on clinical trials
Fatemeh Arabi et al.
EXPERIMENTAL CELL RESEARCH (2018)
Chimeric antigen receptor-engineered T-cell therapy for liver cancer
Yang Chen et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
Xiaobo Cai et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Targeting cancer stem cells in the clinic: Current status and perspectives
Stephanie Annett et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Cancer stem cells: Regulation programs, immunological properties and immunotherapy
Dingxiao Zhang et al.
SEMINARS IN CANCER BIOLOGY (2018)
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
Yao Wang et al.
ONCOIMMUNOLOGY (2018)
Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
Yasushi Akahori et al.
BLOOD (2018)
Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells
Aussara Panya et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Defining Memory CD8 T Cell
Matthew D. Martin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cholangiocarcinoma: Current Knowledge and New Developments
Boris Blechacz
GUT AND LIVER (2017)
Current strategies to improve the safety of chimeric antigen receptor (CAR) modified T cells
Qi-Yu Yang et al.
IMMUNOLOGY LETTERS (2017)
Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
Kai-chao Feng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Potential mechanisms of CD133 in cancer stem cells
Jae-Woo Jang et al.
LIFE SCIENCES (2017)
Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA
Mutita Junking et al.
TUMOR BIOLOGY (2017)
HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation
Josefa A. Rodriguez
ONCOLOGY LETTERS (2017)
Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer
Timothy N. J. Bullock
CURRENT OPINION IN IMMUNOLOGY (2017)
Improving the safety of T-Cell therapies using an inducible caspase-9 gene
Xiaoou Zhou et al.
EXPERIMENTAL HEMATOLOGY (2016)
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
Avery D. Posey et al.
IMMUNITY (2016)
Forty-Year Trends in Cholangiocarcinoma Incidence in the US: Intrahepatic Disease on the Rise
Supriya K. Saha et al.
ONCOLOGIST (2016)
Role of memory T cell subsets for adoptive immunotherapy
Dirk H. Busch et al.
SEMINARS IN IMMUNOLOGY (2016)
CD133, Selectively Targeting the Root of Cancer
Jorg U. Schmohl et al.
TOXINS (2016)
Toxicity and management in CAR T-cell therapy
Challice L. Bonifant et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study
Lung-Ji Chang et al.
BLOOD (2016)
Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas
Vincenzo Cardinale et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Current Insights on Cholangiocarcinoma Research: a Brief Review
Vivek Bhakta Mathema et al.
Asian Pacific Journal of Cancer Prevention (2015)
First-In-Patient Proof of Safety and Efficacy of a 4th Generation Chimeric Antigen Receptor-Modified T Cells for the Treatment of Relapsed or Refractory CD30 Positive Lymphomas
Zhi-Tao Ying et al.
MOLECULAR THERAPY (2015)
Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
Xuekai Zhu et al.
ONCOTARGET (2015)
Variability in immune infiltrates and HLA expression in cholangiocarcinoma
Francesco Sabbatino et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis
Raynoo Thanan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Research progression of CD133 as a marker of cancer stem cells
Hua Zhang et al.
Chinese Journal of Cancer (2012)
Strong expression of CD133 is associated with increased cholangiocarcinoma progression
Kawin Leelawat et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100)
Banchob Sripa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT
M Maruyama et al.
TRANSPLANTATION (2004)
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
M Chawla-Sarkar et al.
APOPTOSIS (2003)
Share Paper
